High flow nasal therapy versus noninvasive ventilation as initial ventilatory strategy in COPD exacerbation: a multicenter non-inferiority randomized trial.
Crit Care. 2020 Dec 14;24(1):692. doi: 10.1186/s13054-020-03409-0.
Crit Care. 2020.
PMID: 33317579
Free PMC article.
Clinical Trial.